Horizon Discovery Group – pharmaceutical daily

September 30, 2019 Off

Horizon Discovery, Glenmark Pharmaceuticals ink license agreement for GS knockout CHO cell line for manufacture of biotherapeutics

Glenmark signs full commercial-use license for Horizon’s gene-edited CHO cells CAMBRIDGE, England–(BUSINESS WIRE)–Horizon Discovery Group plc (LSE: HZD) (“Horizon”), a…

January 24, 2017 Off

Horizon Discovery expects 2016 revenue up 20%

By Dino Mustafić

Horizon Discovery Group expects to see 2016 revenues rise for about 20%, as it expects revenue of at least £24.0 million.

November 9, 2016 Off

Horizon enters into equipment manufacturing deal with CareDx

By Dino Mustafić

Horizon Discovery Group has entered into an Original Equipment Manufacturer (OEM) agreement with CareDx…

October 7, 2015 Off

Horizon In-licenses Oncology Programme from Servier and Enters Option Agreement

By Dino Mustafić

Horizon Discovery Group plc, the international life science company supplying research tools and services that power genomics research and the development of personalised medicines, has announced that its leveraged business unit has signed a programme in-licensing and option agreement with Servier, the independent French research-based pharmaceutical company .

September 16, 2015 Off

Horizon Enters in Cell Line Licensing Agreement with LakePharma

By Dino Mustafić

Horizon Discovery Group plc Enters Bioproduction Cell Line Licensing Agreement with LakePharma, Inc. Horizon Discovery Group plc, the international life…